Australia · Research
Research
Pharmaceuticals
Biotechnology
Healthcare
Neurizon Therapeutics is dedicated to revolutionizing the treatment of neurodegenerative diseases. With a focus on optimizing quality of life for patients, the company is pioneering novel applications for NUZ-001 (S-Monepantel). After a decade of research and development, promising results in preclinical and clinical studies have been achieved, particularly in the treatment of Amyotrophic Lateral Sclerosis (ALS). Neurizon is committed to bringing transformative treatments to patients as quickly as possible, with ongoing trials and partnerships aimed at accelerating approval and global launch.
2000
Founded
Research
Industry
Australia
Location
7,655,678
Ranking
11 employees
Size

Get full access to view complete information
